Skip to content

Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease

Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00965471
Enrollment
940
Registered
2009-08-25
Start date
2006-10-31
Completion date
2009-06-30
Last updated
2009-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Coronary Artery Bypass Graft, Percutaneous Coronary Artery Intervention

Keywords

percutaneous coronary artery intervention, coronary artery bypass graft, acute coronary syndrome

Brief summary

The purpose of this study is to built the standard of Chinese Traditional Medicine test for Post percutaneous coronary artery intervention and coronary artery bypass graft,also for acute coronary syndrome,according to the multi-site、random large sample test.

Interventions

DRUGcipher prescription 1

Drug granules include ginseng,RADIX NOTOGINSENG,prepared RHIZOMA PINELLIAE with alumen radix glyrrhigae calcaren once daily for 180 days

DRUGcipher prescription 2

Placebo include amidon、bitter principles and diluents bases once daily for 180 days

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
CollaboratorOTHER
Guangdong Provincial People's Hospital
CollaboratorOTHER
China-Japan Friendship Hospital
CollaboratorOTHER
Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region
CollaboratorUNKNOWN
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
CollaboratorOTHER
Teaching Hospital of Nanjin University of Traditional Chinese Medicine
CollaboratorUNKNOWN
Second People's Hospital, Fujian Province
CollaboratorOTHER
Liaoning University of Traditional Chinese Medicine
CollaboratorOTHER
Guangzhou Overseas Chinese Hospital
CollaboratorUNKNOWN
Beijing Tongren Hospital
CollaboratorOTHER
Shanghai 10th People's Hospital
CollaboratorOTHER
PLA.The Military General Hospital of Beijing
CollaboratorUNKNOWN
The Sixth Affliated Hospital of Jinan University
CollaboratorUNKNOWN
Beijing Anzhen Hospital
CollaboratorOTHER
Gansu Provincial Hospital
CollaboratorOTHER
Shaanxi Provincial People's Hospital
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
The Fifth Affliated Hospital of Guangxi Medical University
CollaboratorUNKNOWN
Guangzhou University of Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* age40~75 * angina or CAD patient * deficiency of heart-QI and blockage of phlegm and blood stasis in chinese medicine * 1 week after operation,or 1week after drainage tube extraction for CABG * sign a informed consent

Exclusion criteria

* severe cardia failure * severe renal inadequacy * complicating with malignant tumor,reactive alimentary tract hemorrhage and haematological systemic disorder etc. * psychotic * pregnant,lactation

Design outcomes

Primary

MeasureTime frame
dead180±3days

Secondary

MeasureTime frame
cardiovascular event180±3days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026